Country Profile

South Africa

South Africa is one of India's largest pharmaceutical export destinations — $751M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 91% of shipments, with vaccines contributing $20.3M. The compound annual growth rate since FY2015 stands at 4.5%.

🇿🇦 #3 Destination · $751M · 1.6× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$751M
Exports FY2025–26 DGCIS
1.6×
Growth FY2015→2026
2.4%
Share of India Total
#3
Rank Among 178 Markets
4.5%
CAGR FY2015→2026
South Africa is one of India's largest pharmaceutical export destinations — $751M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 91% of shipments, with vaccines contributing $20.3M. The compound annual growth rate since FY2015 stands at 4.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $683M (90.9%) Medicine Ingredients $25.7M (3.4%) Vaccines $20.3M (2.7%) Surgical & Hospital Supplies $12.6M (1.7%) Traditional & Herbal $9.73M (1.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to South Africa in the RBI overseas direct investment dataset (2011–2026).